News

Pfizer asserted that the Committee for Medicinal Products for human use of the European Medicines Agency has disapproved of expanding use of SUTENT to encompass the adjuvant treatment…
Read More...

CEL-SCI Corporation asserted that it was extending the expiration date of its Series DD and Series EE warrants to July 1, 2018. The Series DD and Series EE warrants were issued on…
Read More...

Hong Kong based investment firm, PacBridge Capital Partners has committed to invest C$12,000,000 in Contextual Genomics, leading Canadian Cancer genomics company headquartered in…
Read More...

Pfizer asserted that that the Committee for Medicinal products for Human use of the European Medicines Agency has adopted positive opinions extending marketing authorizations in the EU…
Read More...

AstraZeneca asserted that the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC) has voted in favor of a renewed recommendation for the…
Read More...

NaviGate Cardiac Structures asserted that its catheter-guided GATE valved-stent bioprosthesis became the first Canadian orthotopic valve replacement to treat severe tricuspid…
Read More...

Clovis Oncology claimed an update to the ongoing regulatory review for the Marketing Authorization Application (MAA) for Rucaparib tablets as monotherapy for the treatment of advanced…
Read More...

Merck and Viralytics claimed that the companies have ventured into a definitive agreement that enumerates Merck's acquisition of Viralytics emphasizing on oncolytic immunotherapy…
Read More...

Celgene Corporation asserted that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with respect to the previously announced tender…
Read More...

McKesson Specialty Health oncology and complex care pharmacy services company has been finalized by the Janssen Pharmaceutical Companies of Johnson & Johnson which is considered the…
Read More...

Vertex Pharmaceuticals affirmed initiating the first Phase 3 study of VX-659,  tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis…
Read More...

U.S FDA had asserted the destruction and recall of large volume of kratom-containing dietary supplements that is ideally manufactured and distributed nationwide under the Brand names…
Read More...

Evidenced-based dual diagnosis treatment facility, Chiron Recovery executed a MAT program for the treatment of opioid addiction. Addiction is a chronic disease and just like other…
Read More...

Global pharmaceutical company, Glenmark Pharmaceuticals ventured into an exclusive agreement with Sam Chun Dang Pharma. Co. Ltd. (SCD) to develop, manufacture and market a portfolio of…
Read More...

Dr. Warren Krackov, interventional radiologist specializing in minimally invasive treatment for dialysis access management and other vascular conditions has been named medical director…
Read More...

Medical device company, INVO Bioscience sought FDA clearance for Intravaginal Culture System, INVOcell asserted that Alabama Fertility has augmented its scope of reproductive treatments…
Read More...

Biotechnology company developing innovative products to fill women's unmet healthcare needs, Evofem Biosciences asserted that the U.S FDA has extended Fast Track designation for Amphora…
Read More...

GSK presented at the Center for Disease Control and Prevention Advisory Committee on Immunization Practices meeting that FLUARIX QUADRIVALENT exhibited 63.2% efficacy against moderate…
Read More...

Company dedicated to enhancing healthcare through earlier detection of cancer, Imagion Biosystems, asserted the appointment of Farideh Bischoff, PhD as the Vice President of Clinical…
Read More...

Wholly owned subsidiary of Teleflex, NeoTract emphasizing to address and resolve needs in the field of urology declared that the U.S Food and Drug Administration has sanctioned new…
Read More...